1. Home
  2. VRNA vs ARCB Comparison

VRNA vs ARCB Comparison

Compare VRNA & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • ARCB
  • Stock Information
  • Founded
  • VRNA 2005
  • ARCB 1923
  • Country
  • VRNA United Kingdom
  • ARCB United States
  • Employees
  • VRNA N/A
  • ARCB N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • ARCB Trucking Freight/Courier Services
  • Sector
  • VRNA Health Care
  • ARCB Industrials
  • Exchange
  • VRNA Nasdaq
  • ARCB Nasdaq
  • Market Cap
  • VRNA 2.2B
  • ARCB 2.4B
  • IPO Year
  • VRNA 2017
  • ARCB N/A
  • Fundamental
  • Price
  • VRNA $35.66
  • ARCB $108.39
  • Analyst Decision
  • VRNA Strong Buy
  • ARCB Buy
  • Analyst Count
  • VRNA 6
  • ARCB 14
  • Target Price
  • VRNA $43.83
  • ARCB $130.69
  • AVG Volume (30 Days)
  • VRNA 1.1M
  • ARCB 313.4K
  • Earning Date
  • VRNA 11-04-2024
  • ARCB 11-01-2024
  • Dividend Yield
  • VRNA N/A
  • ARCB 0.44%
  • EPS Growth
  • VRNA N/A
  • ARCB 8.96
  • EPS
  • VRNA N/A
  • ARCB 8.07
  • Revenue
  • VRNA $5,624,000.00
  • ARCB $4,266,908,999.00
  • Revenue This Year
  • VRNA N/A
  • ARCB N/A
  • Revenue Next Year
  • VRNA $554.09
  • ARCB $4.30
  • P/E Ratio
  • VRNA N/A
  • ARCB $13.48
  • Revenue Growth
  • VRNA 1127.95
  • ARCB N/A
  • 52 Week Low
  • VRNA $11.39
  • ARCB $94.77
  • 52 Week High
  • VRNA $40.13
  • ARCB $153.60
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 51.76
  • ARCB 49.64
  • Support Level
  • VRNA $36.49
  • ARCB $112.31
  • Resistance Level
  • VRNA $40.13
  • ARCB $122.10
  • Average True Range (ATR)
  • VRNA 2.01
  • ARCB 5.02
  • MACD
  • VRNA -0.30
  • ARCB 0.34
  • Stochastic Oscillator
  • VRNA 47.60
  • ARCB 40.40

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About ARCB ArcBest Corporation

ArcBest Corp is engaged in logistics operations. The company operates in two operating segments, The Asset-Based segment includes the results of operations of ABF Freight System, Inc. and certain other subsidiaries. The segment operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed LTL services. The services including freight transportation related to managed transportation solutions and other services. The Asset-Light segment includes the results of operations of the Company's service offerings in truckload, ground expedite, dedicated, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.

Share on Social Networks: